The ECFS-CTN cannot guarantee that the information provided here is comprehensive. Please go to the link for detailed and up-to-date information on study background, eligibility criteria, study design, outcome measures, study status, participating sites, sponsor contact information and timelines.

You can also contact the CTN coordinating centre for additional information:

Study Name on (link is external)
Covid-19 Antibody Responses in Cystic Fibrosis (CAR-CF)
Study Drug -
Type of Study Drug  -
Study Title Covid-19 Antibody Responses in Cystic Fibrosis (CAR-CF)
Study Phase -
Study SponsorCTN Consortium

Link on (link is external) 
search for “CAR-CF” and applicable country

Participating ECFS-CTN sitesPlease contact for most recent sitelist
AgePediatric and Adult patients